---
title: An ESR1-Related Gene Signature Identifies Head and Neck Squamous Cell Carcinoma
  with Imputed Susceptibility to Endocrine Therapy
date: '2024-01-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38279245/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240127170650&v=2.18.0
source: heidelberg[Affiliation]
description: Head and neck squamous cell carcinoma (HNSCC) is associated with high
  morbidity and mortality. New personalized treatment strategies represent an unmet
  medical need to improve the overall survival and the quality of life of patients,
  which are often limited by the toxicity of established multimodal treatment protocols.
  Several studies have reported an increased expression of the estrogen receptor 1
  (ESR1) in HNSCC, but its potential role in the disease outcome of these tumors remains
  ...
disable_comments: true
---
Head and neck squamous cell carcinoma (HNSCC) is associated with high morbidity and mortality. New personalized treatment strategies represent an unmet medical need to improve the overall survival and the quality of life of patients, which are often limited by the toxicity of established multimodal treatment protocols. Several studies have reported an increased expression of the estrogen receptor 1 (ESR1) in HNSCC, but its potential role in the disease outcome of these tumors remains ...